Rui Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rui Wang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Chang-Jie Chen
Department of Laboratory Medicine, Bengbu Medical College, Bengbu, Anhui, China
1 shared publication - Feng-Meng Teng
Department of Laboratory Medicine, Bengbu Medical College, Bengbu, Anhui, China
1 shared publication - Qiong Wu
Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui 233000, China
1 shared publication - Shukui Qin
Nanjing Medical University
1 shared publication
Latest Publications
- Open Access
- 31 October 2010
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 3 (1) , 43
Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells
Hepatocellular carcinoma (HCC) still is a big burden for China. In recent years, the third-generation platinum compounds have been proposed as potential active agents for HCC. However, more experimental and clinical data are warranted to support the proposal. In the present study, the effect of lobaplatin was assessed in five HCC cell lines and the underlying molecular mechanisms in terms of cell cycle kinetics were explored.
- 31 October 2010
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 3 (1) , 43
Open AccessLobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells
Hepatocellular carcinoma (HCC) still is a big burden for China. In recent years, the third-generation platinum compounds have been proposed as potential active agents for HCC. However, more experimental and clinical data are warranted to support the proposal. In the present study, the effect of lobaplatin was assessed in five HCC cell lines and the underlying molecular mechanisms in terms of cell cycle kinetics were explored.